Quoin Pharmaceuticals (QNRX) has launched the “NETHERTON NOW” campaign to shed light on the profound and poorly understood impacts of Netherton ...

Quoin Pharmaceuticals Ltd. (QNRX), a specialty pharmaceutical company currently valued at $2.42 million, announced today the initiation of the "NETHERTON NOW" campaign aimed at increasing awareness of ...

The recent 13% drop in Quoin Pharmaceuticals, Ltd.'s (NASDAQ:QNRX) stock could come as a blow to insiders who purchased US$580.9k worth of stock at an average buy price of US$0.48 over the past 12 ...

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead ...

Quoin Pharmaceuticals Ltd (QNRX) experienced notable stock volatility following its Q4 2023 earnings call, as the company detailed its financial performance, strategic developments, and future ...

After hours: 7:58:08 p.m. EST ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

ASHBURN, Va. - Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a company specializing in rare and orphan diseases, has received clearance from the U.S. Food and Drug Administration... ByInvesting.com • 04 ...